Novartis teamed up with high ventilation to do smart medical care
Novartis has announced a joint venture with Qualcomm Ventures to form a joint investment company that combines Novartis' expertise in drug development and production with Qualcomm's expertise in digital and mobile technologies to focus on discovering start-ups with new medical technologies or products. team. Although Novartis is a pharmaceutical company, the scope of the investment is “not limited to drugsâ€.
David Epstein, head of Novartis Pharmaceuticals, said that he is very concerned about the team that provides integrated solutions for doctors and patients, or any technological innovation that can lead the industry.
As for Novartis’s own role, it is hoped that digital health care will be used to provide patients with appropriate medicines at the right time, such as medical devices that support telephone functions, mobile applications, wearable devices, and the use of big data and small data. Techniques for accurate delivery of drugs to patients and more accurate drug economic analysis.
There are many new funds for mobile health care . For example, Aier Ophthalmology established three M&A funds in 2014, and pharmaceutical companies have been active in strategic investment M&A. Roche has invested in cancer data analysis team FM, Biopharmaceuticals. The company Genentech injected $60 million into 23andMe to share the genomic data of the latter's Parkinson's disease patients.
Green & White Onion,Dehydrated onion ring,Dehydrated scallion,Condiment dehydrated green onion,Dehydrated edible leek
Jiangsu Tiankang Food Co., Ltd. , https://www.tiankangfood.com